John Peter Plastaras MD PhD
Gastrointestinal Cancer, Hematologic Malignancies
University of Pennsylvania, Dept of Radiation Oncology
Join to View Full Profile
3400 Civic Center Blvd# ConcoursPhiladelphia, PA 19104
Phone+1 215-662-2428
Fax+1 215-349-5923
Dr. Plastaras is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2003 - 2007
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2002 - 2003
Vanderbilt University School of MedicineClass of 2002
Certifications & Licensure
PA State Medical License 2003 - 2026
NJ State Medical License 2008 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Proton Radiotherapy for Recurrent Tumors Start of enrollment: 2010 Feb 01
- Proton Radiotherapy for Upper Gastrointestinal Malignancies Start of enrollment: 2011 Aug 01
- Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
- Join now to see all
Publications & Presentations
PubMed
- Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials.Grace Lee, Bailey Nelson, Julie Koenig, John P Plastaras, James M Metz
International Journal of Radiation Oncology, Biology, Physics. 2025-05-01 - Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter Study.Nikhil Yegya-Raman, John P Plastaras, Christopher M Wright, Monica R Chelius, Siqi Zhang
Blood Advances. 2025-04-09 - Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome.Omar Elghawy, Jonathan H Sussman, Austin G Yang, Colin J Thomas, Jordan S Carter
JAMA Dermatology. 2025-04-02
Journal Articles
- More Accurate and Efficient Segmentation of Organs‐at‐Risk in Radiotherapy with Convolutional Neural Networks CascadesAlexander Lin, John P Plastaras, Ying Xiao, Medical Physics
Abstracts/Posters
- A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell TherapyJohn Plastaras, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Concurrent Use of Novel Agents and Radiation Is Tolerated in Lymphoma PatientsJohn Plastaras, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
New $224 Million Proton Therapy Center Coming to Penn PresbyterianApril 27th, 2025
Radiation Prior to CAR T-cell Therapy in Non-Hodgkin’s Lymphoma May Ease Side Effects, Study SuggestsOctober 1st, 2019
Radiation May Lower Potential for Side Effects of CAR T Therapy in Non-Hodgkin's LymphomaSeptember 17th, 2019- Join now to see all
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Lymphoma, American College of Radiology 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
